Xia Bu
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 1%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Immunology 14
- Immune Cell Function and Interaction 7
- Immunotherapy and Immune Responses 5
- Galectins and Cancer Biology 3
- Immune cells in cancer 3
- Oncology 11
- Cancer Immunotherapy and Biomarkers 9
- CAR-T cell therapy research 2
- Co-authors
- Gordon J. Freeman (14 shared papers)Avinash Sahu (1 shared paper)Peng Jiang (1 shared paper)Xihao Hu (1 shared paper)Deng Pan (1 shared paper)Nicole Traugh (1 shared paper)Bo Li (1 shared paper)Myles Brown (1 shared paper)
- Journals
- Advances in experimental medicine and biology (2 papers)The Journal of Immunology (2 papers)Blood (2 papers)PLoS Pathogens (1 paper)Nature Communications (1 paper)
- Partner nations
- United StatesChinaSpain
In The Last Decade
Xia Bu
25 papers receiving 5.8k citations
Xia Bu's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 2.1k
- Immunology 1.7k
- Cancer Research 919
- Pulmonary and Respiratory Medicine 1.7k
- Molecular Biology 1.8k
Countries citing papers authored by Xia Bu
This map shows the geographic impact of Xia Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xia Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xia Bu more than expected).
Fields of papers citing papers by Xia Bu
This network shows the impact of papers produced by Xia Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xia Bu. The network helps show where Xia Bu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xia Bu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response Hit paper breakdown → | 2018 | 3400 |
| 2 | Cyclin D–CDK4 kinase destabilizes PD-L1 via cullin 3–SPOP to control cancer immune surveillance Hit paper breakdown → | 2017 | 766 |
| 3 | 2013 | 283 | |
| 4 | 2010 | 282 | |
| 5 | 2014 | 263 | |
| 6 | 2021 | 167 | |
| 7 | 2002 | 122 | |
| 8 | 2018 | 114 | |
| 9 | 2019 | 96 | |
| 10 | 2004 | 72 | |
| 11 | 2010 | 63 | |
| 12 | 2023 | 58 | |
| 13 | 2005 | 31 | |
| 14 | 2017 | 28 | |
| 15 | 2023 | 21 | |
| 16 | 2020 | 20 | |
| 17 | 2011 | 19 | |
| 18 | 2005 | 17 | |
| 19 | 2017 | 16 | |
| 20 | 2021 | 12 |
About Xia Bu
Xia Bu is a scholar working on Immunology, Oncology, Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience, having authored 27 papers that have together received 5.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Immune Cell Function and Interaction (7 papers), Immunotherapy and Immune Responses (5 papers), Galectins and Cancer Biology (3 papers), Immune cells in cancer (3 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), CAR-T cell therapy research (2 papers) and Ginseng Biological Effects and Applications (2 papers). The work is most often cited by research in Oncology (2.1k citations), Immunology (1.7k citations), Cancer Research (919 citations), Pulmonary and Respiratory Medicine (1.7k citations) and Molecular Biology (1.8k citations). Xia Bu has collaborated with scholars based in United States, China and Spain. Frequent co-authors include Gordon J. Freeman, Avinash Sahu, Peng Jiang, Xihao Hu, Deng Pan, Nicole Traugh, Bo Li, Myles Brown, Ziyi Li and Jingxin Fu. Their work appears in journals such as Advances in experimental medicine and biology, The Journal of Immunology, Blood, PLoS Pathogens and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.